Wholesale XCE Tirzepatide GLP-1 GIP Dual Agonist for Scientific Studies

XCE Tirzepatide (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. This compound demonstrates superior efficacy in glucose control and weight management compared to selective GLP-1 receptor agonists.

The XCE Tirzepatide formulation shows greater affinity for GIP receptors than GLP-1 receptors, producing enhanced reductions in hyperglycemia. Research indicates it effectively mimics natural GIP action at the GIP receptor while maintaining GLP-1 receptor activity.

Our XCE Tirzepatide is supplied as a high purity white powder (>98%) with molecular formula C225H348N48O68 and molar mass of 4813.45. The product is carefully packaged to maintain stability during storage and transportation.

For research use only. Not for human consumption. Proper laboratory handling procedures should be followed when working with this compound.

XCE Tirzepatide represents an important advancement in diabetes research, offering dual receptor activity that may provide superior metabolic effects compared to single receptor agonists. Researchers should store the product at recommended temperatures to maintain stability.